The mineralization regulator ANKH mediates cellular efflux of ATP, not pyrophosphate
F Szeri, F Niaziorimi, S Donnelly… - Journal of Bone and …, 2020 - academic.oup.com
The plasma membrane protein ankylosis homologue (ANKH, mouse ortholog: Ank) prevents
pathological mineralization of joints by controlling extracellular levels of the mineralization …
pathological mineralization of joints by controlling extracellular levels of the mineralization …
ENPP1 enzyme replacement therapy improves ectopic calcification but does not rescue skeletal phenotype in a mouse model for craniometaphyseal dysplasia
EJ Reichenberger, K O'Brien, A Hatori… - JBMR plus, 2024 - academic.oup.com
Craniometaphyseal dysplasia (CMD) is a rare genetic bone disorder, characterized by
progressive thickening of craniofacial bones and flared metaphyses of long bones …
progressive thickening of craniofacial bones and flared metaphyses of long bones …
[HTML][HTML] Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia
JS Barros, D Braddock, TO Carpenter - Bone Reports, 2023 - Elsevier
Craniometaphyseal dysplasia (CMD) is an infrequently occurring skeletal dysplasia often
caused by a mutation in ANKH. The most common features are early and progressive …
caused by a mutation in ANKH. The most common features are early and progressive …
Ankylosis homologue mediates cellular efflux of ATP, not pyrophosphate
F Szeri, F Niaziorimi, S Donnelly, N Fariha… - bioRxiv, 2021 - biorxiv.org
The plasma membrane protein Ankylosis Homologue (ANKH, mouse ortholog: Ank)
prevents pathological mineralization of joints by controlling extracellular levels of the …
prevents pathological mineralization of joints by controlling extracellular levels of the …